High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing home residents

Hofstee, Marloes I; Kaczorowska, Joanna; Postema, Abigail; Zomer, Erna; van Waalwijk, Maren; Jonathans, Gustaaf; de Rond, Lia GH; Smits, Gaby; van den Hoogen, Lotus L; den Hartog, Gerco; Buisman, Anne-Marie

doi:10.1186/s12979-024-00495-4

Fig. 1

From: High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing home residents

Study design with number of study participants, vaccine and sampling timepoints, and the different dominant SARS-CoV-2 variant periods. (a) Information on the number of COVID-19 confirmed cases and deaths of older adults aged 70 years or over who live in a nursing home in the Netherlands. Data was collected until the 11th of July 2023 and obtained from data.rivm.nl/covid-19/. Additionally, information on vaccine dose administration, sampling timepoints, and circulating SARS-CoV-2 variants of concern have been indicated in the graph. (b) A flowchart depicting vaccine dose administration and sampling timepoints together with information on the number of study participants per timepoint

Back to article page

Fig. 1

Immunity & Ageing

Contact us